Clinical trials
Active, not recruiting Phase 1/2 Hodgkin Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 3 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AIDS Malignancy Consortium | 1 |
| Fondazione Italiana Linfomi - ETS | 1 |
| GlaxoSmithKline | 1 |
| Immunitas Therapeutics | 1 |
| M.D. Anderson Cancer Center | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Ossium Health, Inc. | 1 |
| Roswell Park Cancer Institute | 1 |
| St. Petersburg State Pavlov Medical University | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hodgkin Disease | 10 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
| Lymphoma, Follicular | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Anemia, Aplastic | 2 |
| Burkitt Lymphoma | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Lymphoma | 2 |
| Lymphoma, Mantle-Cell | 2 |
| Multiple Myeloma | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.